Jokinen Vesa, Tapanainen Jari M, Seppänen Tapio, Huikuri Heikki V
Division of Cardiology, Department of Medicine, University of Oulu, Oulu, Finland.
Am J Cardiol. 2003 Oct 15;92(8):907-12. doi: 10.1016/s0002-9149(03)00968-8.
Previous studies have shown that indexes describing heart rate (HR) dynamics may predict subsequent deaths of patients after an acute myocardial infarction (AMI). Because beta-blocking (BB) drugs affect both mortality and HR dynamics, the prognostic power of measurements of HR dynamics may have changed in the current era of BB therapy. This study assessed the temporal changes and prognostic significance of time-domain, spectral, and fractal indexes of HR variability along with HR turbulence after an AMI among patients with optimized BB medication. SD of NN intervals, spectral indexes, the short-term fractal scaling exponent (alpha(1)), power-law slope (beta), and turbulence onset and slope were measured in 600 patients at 5 to 7 days after AMI and in 416 patients at 12 months after AMI. In the multivariate analysis, after adjusting for clinical variables, only reduced fractal HR indexes, alpha1 and beta (p <0.01 for both), turbulence onset, and slope (p <0.05 for both), measured at the convalescent phase after AMI, predicted subsequent cardiac death. All time-domain and spectral HR variability indexes and turbulence onset increased significantly during the 12-month period after AMI (p <0.001 for all), whereas the fractal indexes and turbulence slope remained unchanged. Late after AMI, reduced beta (p <0.05) and turbulence slope (p <0.01) were the only independent predictors of cardiac mortality. Traditional time-domain and spectral measurements of HR variability and turbulence onset improved significantly after AMI, whereas the fractal HR dynamics and turbulence slope remained stable. Fractal HR variability and HR turbulence retain their prognostic power in the BB era, when measured either at the convalescent or late phase after AMI.
既往研究表明,描述心率(HR)动态变化的指标可预测急性心肌梗死(AMI)后患者的后续死亡情况。由于β受体阻滞剂(BB)药物会影响死亡率和HR动态变化,在当前BB治疗时代,HR动态变化测量的预后能力可能已发生改变。本研究评估了优化BB药物治疗的AMI患者中,HR变异性的时域、频谱和分形指标以及HR湍流的时间变化和预后意义。在600例AMI后5至7天的患者以及416例AMI后12个月的患者中测量了NN间期标准差、频谱指标、短期分形标度指数(alpha(1))、幂律斜率(beta)以及湍流起始和斜率。在多变量分析中,校正临床变量后,仅在AMI后恢复期测量的分形HR指标降低,即alpha1和beta(两者均p<0.01)、湍流起始和斜率(两者均p<0.05)可预测后续心源性死亡。所有时域和频谱HR变异性指标以及湍流起始在AMI后的12个月期间均显著增加(所有均p<0.001),而分形指标和湍流斜率保持不变。AMI后期,beta降低(p<0.05)和湍流斜率降低(p<0.01)是心源性死亡的唯一独立预测因素。AMI后,传统的时域和频谱HR变异性测量以及湍流起始显著改善,而分形HR动态变化和湍流斜率保持稳定。在BB治疗时代,无论是在AMI后的恢复期还是后期进行测量,分形HR变异性和HR湍流均保留其预后能力。